Rs 1,840 Puts — 2.7% Below Current Price — Draw 2,530 Contracts on Sun Pharmaceutical Industries Ltd

Put Options Event and Cash Market Context

On 23 Jun 2026, Sun Pharmaceutical Industries Ltd saw significant put option activity concentrated around three strikes expiring on 30 Jun 2026. The Rs 1,840 strike led with 2,530 contracts traded, followed closely by Rs 1,860 with 2,628 contracts and Rs 1,800 with 3,360 contracts. The underlying stock closed at Rs 1,892, just 0.98% shy of its 52-week high of Rs 1,916.6, and has gained 5.4% over the past five sessions. The day's high touched Rs 1,902.4, reflecting a steady upward momentum.

The total turnover for these put trades was substantial, with Rs 73.4 lakhs at the Rs 1,860 strike alone. Open interest figures show 1,780 contracts at Rs 1,840, 1,450 at Rs 1,860, and 2,653 at Rs 1,800, indicating a mix of fresh and existing positions. The stock outperformed its sector by 0.4% and the Sensex by 1.48% on the day, while trading above all major moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling a robust technical backdrop. Is this put activity a sign of protective hedging or a bearish stance?

Strike Price Analysis: Moneyness and Intent

The Rs 1,840 strike sits approximately 2.7% below the current market price of Rs 1,892, placing it slightly out-of-the-money (OTM). The Rs 1,860 strike is closer, about 1.7% OTM, while the Rs 1,800 strike is 5.0% OTM. The concentration of contracts at these strikes suggests a strategic positioning rather than speculative directional bets at deep in-the-money (ITM) levels.

OTM puts bought on a rising stock often indicate hedging activity, protecting gains from a recent rally. Conversely, if these were ITM puts or ATM puts on a declining stock, the interpretation would lean more towards bearish positioning. The Rs 1,840 strike’s proximity to the underlying price and the stock’s recent gains support the hedging hypothesis. Could these strikes be chosen to guard against a pullback to key moving average support?

Interpreting the Put Activity: Hedging, Bearish, or Put Writing?

Put options inherently carry ambiguous signals. The three main interpretations are: put buying as a bearish bet, protective hedging of existing long positions, or put writing (selling puts) as a bullish strategy expecting the stock to hold above the strike.

Given the stock’s steady rise over five days and its position above all major moving averages, the surge in OTM put contracts is more consistent with hedging. Investors may be safeguarding profits against a potential short-term correction rather than anticipating a sharp decline. The Rs 1,840 strike is close enough to act as a safety net without signalling outright bearish conviction.

Put writing is less likely here given the high turnover and open interest at these strikes, which suggests active buying rather than premium collection. However, some put selling could be present, especially at the Rs 1,860 strike, where turnover is highest, reflecting a possible mix of strategies.

Open Interest and Contracts: Fresh Positioning or Adjustments?

The ratio of contracts traded to open interest provides insight into the nature of the activity. At the Rs 1,840 strike, 2,530 contracts traded against an open interest of 1,780, a ratio of approximately 1.42:1, indicating significant fresh activity but also some existing positions being adjusted. The Rs 1,860 strike shows a higher turnover of 2,628 contracts against 1,450 open interest, a ratio of 1.81:1, suggesting even more fresh positioning.

Such ratios imply that the put activity is not merely rollovers or closing trades but involves new hedging or speculative bets. The Rs 1,800 strike, with 3,360 contracts traded and 2,653 open interest, shows a lower ratio of 1.27:1, indicating a mix of fresh and ongoing positions. This pattern supports the view that investors are actively managing risk around these strikes rather than purely betting on a decline.

Cash Market Momentum and Technical Alignment

Sun Pharmaceutical Industries Ltd has been on a steady upward trajectory, gaining 5.4% over the last five sessions and outperforming its sector and the Sensex. The stock trades comfortably above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, a technical configuration that typically signals strength.

However, delivery volumes have declined by 18.68% against the five-day average, suggesting that the rally may lack robust participation from long-term holders. This thinning delivery volume could be a reason for investors to hedge their positions with puts, protecting against a potential pullback despite the positive price action. Is this a prudent hedge or a sign of underlying caution?

Delivery Volume and Quality of Participation

Delivery volume on 22 Jun 2026 was 10.72 lakh shares, down 18.68% from the five-day average, indicating reduced investor participation in the rally. This decline in delivery volume contrasts with the price gains, suggesting that short-term traders or non-delivery participants may be driving the move. Such a scenario often prompts long-term holders to seek protection through put options, especially OTM strikes that provide a buffer without excessive cost.

Conclusion: Protective Hedging Dominates the Put Activity

The combined data points to the put activity on Sun Pharmaceutical Industries Ltd being primarily protective hedging rather than outright bearish bets or put writing. The stock’s recent gains, proximity to all major moving averages, and the strike prices chosen all align with a strategy to guard against a modest pullback rather than a sharp decline.

While some put writing cannot be ruled out, the high turnover and open interest ratios suggest active buying of puts to manage risk. Investors appear to be balancing optimism with caution, reflecting a nuanced view of the stock’s near-term prospects. Should investors consider similar protective strategies or interpret this as a signal to reassess their exposure?

Key Data at a Glance

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today